9_Mr Adlide_Roundtable_Vaccines affordability
13
The best shot: reaching 22 million missed children Geoff Adlide, Director Advocacy and Public Policy GAVI Alliance A seminar on accelerating access to vaccination Oslo, 14 October 2013
-
Upload
msf-access-campaign -
Category
Documents
-
view
216 -
download
0
description
Presentation by Mr Geoff Adlide, GAVI Alliance , at the MSF Oslo Seminar "The best shot: reaching 22 million missed children - A seminar on accelerating access to vaccination". Session: Roundtable debate - how can we ensure affordable vaccines?
Transcript of 9_Mr Adlide_Roundtable_Vaccines affordability
The best shot: reaching 22 million missed children Geoff Adlide, Director Advocacy and Public Policy GAVI Alliance
A seminar on accelerating access to vaccination
Oslo, 14 October 2013
A seminar on accelerating access to vaccination 14 October 2013
Mission and strategic goals 2011–2015
The vaccine goal Accelerate the uptake and use of underused and new vaccines
The health systems goal Contribute to strengthening the capacity of integrated health systems to deliver immunisation
The financing goal Increase the predictability of global financing and improve the sustainability of national financing for immunisation
The market shaping goal Shape vaccine markets to ensure adequate supply of appropriate, quality vaccines at low and sustainable prices
1 2 3 4
To save children’s lives and protect people’s health by increasing access to immunisation in poor countries
A seminar on accelerating access to vaccination 14 October 2013
GAVI’s supply and procurement objectives
A seminar on accelerating access to vaccination 14 October 2013
Increased competition reduces vaccine price
Price decline of pentavalent vaccine and number of manufacturers
Source: UNICEF Supply Division, 2013
A seminar on accelerating access to vaccination 14 October 2013
Source: UNICEF Supply Division, 2013
Vaccine prices and supply security As of the end of 2012
A seminar on accelerating access to vaccination 14 October 2013
Pentavalent roadmap
Market Landscape
5 suppliers Supply capacity in line with demand 2013-20 Risks remain to supply security 2012 WAP = USD 2.17/dose (-40% vs 2006)
Stakeholder Action Plan
Optimize allocations Support NRAs Supply continuity Encourage new entrants Optimize presentation mix
Market Shaping Targets
1. No major supplier exits 2. No major supply failure 3. No NRA failure 4. 1 new supplier 5. WAP continued
decrease
Ambition
No supply disruption Downward price trend
A seminar on accelerating access to vaccination 14 October 2013
GAVI’s co-financing policy: country ownership and steps to sustainability
Country groupings:
Low-income countries (<US$ 1,025 per capita GNI) pay
US$ 0.20 per dose
Intermediate countries (US$ 1,025–US$ 1,550) increase co-payments by 15% per year
Graduating countries (>US$ 1,550) increase payments steadily to reach sustainability after five years
A seminar on accelerating access to vaccination 14 October 2013
How the co-financing policy works
Source: GAVI Alliance 2013
A seminar on accelerating access to vaccination 14 October 2013
Fiscal space not the main bottleneck to sustain vaccines post-GAVI
0.00%
0.20%
0.40%
0.60%
0.80%
1.00%
1.20%
1.40%
1.60%
1.80%
2.00%
2012 2013 2014 2015 2016 2017 2018 2019 2020
Angola
Timor-Leste
Congo Rep.
Per
cent
age
of G
ovt.
heal
th e
xpen
ditu
re
Source: GAVI Secretariat with data from GAVI Strategic Demand Forecast; IMF; NHA. See Health Affairs June 2011
A seminar on accelerating access to vaccination 14 October 2013
Thank you
GAVI/2011/Ed Harris
A seminar on accelerating access to vaccination 14 October 2013
Tiered pricing
Source: GAVI Alliance, 2012
A seminar on accelerating access to vaccination 14 October 2013
Co-financing: countries fulfilling commitments
Source: GAVI Alliance data as of 1 September 2013
A seminar on accelerating access to vaccination 14 October 2013
Pentavalent Tender
